Is Aurinia Pharmaceuticals Inc. (AUPH) a Buy, Sell, or Hold?
Aurinia Pharmaceuticals Inc.
NASDAQ:AUPH
$15.98 USD
-$0.05 (-0.31%)
- Volume
- 824.38K
- Average Volume
- 1.5M
- Market Capitalization
- $2.06B
- P/E Ratio
- 7.13
- Dividend Yield
- 0.00%
- Price Target
- $13.00
- Year High
- $19.25
- Year Low
- $8.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.55
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
34
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
17
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 700.7K
AUPH Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
AUPH Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Johnson Craig A | director | 2026-06-04 | A-Award | 15.67 | 2026-06-08 |
| Goetz Kathleen | director | 2026-06-04 | A-Award | 15.67 | 2026-06-08 |
| Nova Tina Susan | director | 2026-06-04 | A-Award | 15.67 | 2026-06-08 |
| Bailey Jeffrey Allen | director | 2026-06-04 | A-Award | 15.67 | 2026-06-08 |
| TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | 2026-06-02 | P-Purchase | 15.28 | 2026-06-02 |
| TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | 2026-06-01 | P-Purchase | 15.34 | 2026-06-02 |
| TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | 2026-06-01 | P-Purchase | 15.28 | 2026-06-02 |
| TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | 2026-05-29 | P-Purchase | 15.31 | 2026-06-02 |
| TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | 2026-05-29 | P-Purchase | 15.35 | 2026-06-02 |
| TANG KEVIN | director, 10 percent owner, officer: Chief Executive Officer | 2026-06-02 | J-Other | 15 | 2026-06-02 |
| Robertson Stephen P. | officer: Chief Legal Officer | 2026-05-18 | A-Award | 0 | 2026-05-20 |
| Hearne Michael S | officer: Chief Financial Officer | 2026-05-18 | A-Award | 0 | 2026-05-20 |
| Hearne Michael S | officer: Chief Financial Officer | 2026-05-18 | A-Award | 15.28 | 2026-05-20 |
| Cole Ryan | officer: Chief Operating Officer | 2026-05-18 | A-Award | 0 | 2026-05-20 |
| Cole Ryan | officer: Chief Operating Officer | 2026-05-18 | A-Award | 15.28 | 2026-05-20 |
| Cole Ryan | officer | 2026-03-23 | 0 | 2026-04-02 | |
| Hearne Michael S | officer | 2026-03-23 | 0 | 2026-04-02 | |
| Keenan Greg | officer: SVP, Chief Medical Officer | 2026-03-06 | F-InKind | 14.32 | 2026-03-10 |
| TANG KEVIN | director | 2026-03-03 | P-Purchase | 14.22 | 2026-03-03 |
| TANG KEVIN | director | 2026-03-02 | P-Purchase | 14.21 | 2026-03-03 |
| TANG KEVIN | director | 2026-03-02 | P-Purchase | 14.33 | 2026-03-03 |
| TANG KEVIN | director | 2026-02-27 | P-Purchase | 14.38 | 2026-03-03 |
| TANG KEVIN | director | 2026-02-27 | P-Purchase | 14.12 | 2026-03-03 |
| TANG KEVIN | director | 2026-02-27 | P-Purchase | 13.9 | 2026-03-03 |
| Miller Joseph M | officer: Chief Financial Officer | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Miller Joseph M | officer: Chief Financial Officer | 2026-03-02 | F-InKind | 14.21 | 2026-03-03 |
| Miller Joseph M | officer: Chief Financial Officer | 2026-02-27 | A-Award | 13.97 | 2026-03-03 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2026-03-02 | F-InKind | 14.21 | 2026-03-03 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2026-02-27 | A-Award | 13.97 | 2026-03-03 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2026-03-02 | F-InKind | 14.21 | 2026-03-03 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2026-02-27 | A-Award | 13.97 | 2026-03-03 |
| Keenan Greg | officer: SVP, Chief Medical Officer | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Keenan Greg | officer: SVP, Chief Medical Officer | 2026-02-27 | A-Award | 13.97 | 2026-03-03 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2026-02-27 | A-Award | 0 | 2026-03-03 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2026-03-02 | F-InKind | 14.21 | 2026-03-03 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2026-02-27 | A-Award | 13.97 | 2026-03-03 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2026-02-20 | F-InKind | 14.4 | 2026-02-23 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2026-02-20 | F-InKind | 14.4 | 2026-02-23 |
| Miller Joseph M | officer: Chief Financial Officer | 2026-02-20 | F-InKind | 14.4 | 2026-02-23 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2026-02-20 | F-InKind | 14.4 | 2026-02-23 |
| Keenan Greg | officer: SVP, Chief Medical Officer | 2026-02-02 | F-InKind | 14.53 | 2026-02-03 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2026-01-02 | A-Award | 0 | 2026-01-05 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2026-01-02 | F-InKind | 15.95 | 2026-01-05 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2026-01-02 | A-Award | 0 | 2026-01-05 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2026-01-02 | F-InKind | 15.95 | 2026-01-05 |
| Miller Joseph M | officer: Chief Financial Officer | 2026-01-02 | A-Award | 0 | 2026-01-05 |
| Miller Joseph M | officer: Chief Financial Officer | 2026-01-02 | F-InKind | 15.95 | 2026-01-05 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2026-01-02 | A-Award | 0 | 2026-01-05 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2026-01-02 | F-InKind | 15.95 | 2026-01-05 |
| Bailey Jeffrey Allen | director | 2025-11-21 | F-InKind | 15.68 | 2025-11-24 |
| Johnson Craig A | director | 2025-11-21 | F-InKind | 15.68 | 2025-11-24 |
| TANG KEVIN | director | 2025-08-05 | P-Purchase | 11.68 | 2025-08-05 |
| TANG KEVIN | director | 2025-08-04 | P-Purchase | 11.34 | 2025-08-05 |
| TANG KEVIN | director | 2025-08-01 | P-Purchase | 10.12 | 2025-08-05 |
| Keenan Greg | officer: Chief Medical Officer | 2025-08-01 | S-Sale | 10.5 | 2025-08-05 |
| Nova Tina Susan | director | 2025-05-16 | A-Award | 8.15 | 2025-05-16 |
| Johnson Craig A | director | 2025-05-16 | A-Award | 8.15 | 2025-05-16 |
| Goetz Kathleen | director | 2025-05-16 | A-Award | 8.15 | 2025-05-16 |
| Bailey Jeffrey Allen | director | 2025-05-16 | A-Award | 8.15 | 2025-05-16 |
| Nova Tina Susan | director: | 2025-05-15 | 0 | 2025-05-16 | |
| Goetz Kathleen | director: | 2025-05-15 | 0 | 2025-05-16 | |
| Keenan Greg | officer: Chief Medical Officer | 2025-03-07 | S-Sale | 8.23 | 2025-03-07 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2025-03-03 | A-Award | 0 | 2025-03-04 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2025-03-03 | S-Sale | 8 | 2025-03-04 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2025-02-28 | A-Award | 0 | 2025-03-04 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2025-03-04 | S-Sale | 7.92 | 2025-03-04 |
| Greenleaf Peter | director, officer: Chief Executive Officer | 2025-02-28 | A-Award | 7.55 | 2025-03-04 |
| Keenan Greg | officer: Chief Medical Officer | 2025-02-28 | A-Award | 0 | 2025-03-04 |
| Keenan Greg | officer: Chief Medical Officer | 2025-03-03 | S-Sale | 8 | 2025-03-04 |
| Keenan Greg | officer: Chief Medical Officer | 2025-02-28 | A-Award | 7.55 | 2025-03-04 |
| Miller Joseph M | officer: Chief Financial Officer | 2025-03-03 | A-Award | 0 | 2025-03-04 |
| Miller Joseph M | officer: Chief Financial Officer | 2025-03-03 | S-Sale | 8 | 2025-03-04 |
| Miller Joseph M | officer: Chief Financial Officer | 2025-02-28 | A-Award | 0 | 2025-03-04 |
| Miller Joseph M | officer: Chief Financial Officer | 2025-03-04 | S-Sale | 7.92 | 2025-03-04 |
| Miller Joseph M | officer: Chief Financial Officer | 2025-02-28 | A-Award | 7.55 | 2025-03-04 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2025-03-03 | A-Award | 0 | 2025-03-04 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2025-03-03 | S-Sale | 8 | 2025-03-04 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2025-02-28 | A-Award | 0 | 2025-03-04 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2025-03-04 | S-Sale | 7.92 | 2025-03-04 |
| Robertson Stephen P. | officer: EVP, General Counsel | 2025-02-28 | A-Award | 7.55 | 2025-03-04 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2025-03-03 | A-Award | 0 | 2025-03-04 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2025-03-03 | S-Sale | 8 | 2025-03-04 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2025-03-04 | S-Sale | 7.92 | 2025-03-04 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2025-02-28 | A-Award | 0 | 2025-03-04 |
| Donley Matthew Maxwell | officer: Chief Operating Officer | 2025-02-28 | A-Award | 7.55 | 2025-03-04 |
| TANG KEVIN | director | 2025-03-04 | P-Purchase | 8.09 | 2025-03-04 |
| TANG KEVIN | director | 2025-03-04 | P-Purchase | 7.92 | 2025-03-04 |
| TANG KEVIN | director | 2025-03-04 | P-Purchase | 8 | 2025-03-04 |
| TANG KEVIN | director | 2025-03-03 | P-Purchase | 8.02 | 2025-03-04 |
| TANG KEVIN | director | 2025-03-03 | P-Purchase | 7.97 | 2025-03-04 |
| TANG KEVIN | director | 2025-02-28 | P-Purchase | 7.85 | 2025-03-04 |
| TANG KEVIN | director | 2024-12-09 | P-Purchase | 9.09 | 2024-12-09 |
| TANG KEVIN | director | 2024-12-06 | P-Purchase | 9.01 | 2024-12-09 |
| TANG KEVIN | director | 2024-12-05 | P-Purchase | 8.91 | 2024-12-09 |
| Smith Karen L. | director | 2024-11-21 | A-Award | 0 | 2024-11-25 |
| Smith Karen L. | director | 2024-11-21 | A-Award | 8.24 | 2024-11-25 |
| Leversage Jill | director | 2024-11-21 | A-Award | 0 | 2024-11-25 |
| Leversage Jill | director | 2024-11-21 | A-Award | 8.24 | 2024-11-25 |